These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33975336)

  • 1. The pharmacodynamics of minocycline alone and in combination with rifampicin against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infection.
    Noel AR; Attwood M; Bowker KE; MacGowan AP
    J Antimicrob Chemother; 2021 Jun; 76(7):1840-1844. PubMed ID: 33975336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of minocycline against Staphylococcus aureus in an in vitro pharmacokinetic model.
    Bowker KE; Noel AR; Macgowan AP
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4370-3. PubMed ID: 18519719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacodynamics of fosfomycin against Staphylococcus aureus studied in an in vitro model of infection.
    Noel A; Attwood M; Bowker K; MacGowan A
    Int J Antimicrob Agents; 2020 Jul; 56(1):105985. PubMed ID: 32330585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of tigecycline against phenotypically diverse Staphylococcus aureus isolates in a murine thigh model.
    Crandon JL; Banevicius MA; Nicolau DP
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1165-9. PubMed ID: 19114676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics of ceftaroline against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infection.
    MacGowan AP; Noel AR; Tomaselli S; Bowker KE
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2451-6. PubMed ID: 23459495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model.
    Baldoni D; Furustrand Tafin U; Aeppli S; Angevaare E; Oliva A; Haschke M; Zimmerli W; Trampuz A
    Int J Antimicrob Agents; 2013 Sep; 42(3):220-5. PubMed ID: 23880168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    Rose WE; Poppens PT
    J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of razupenem (PZ601) studied in an in vitro pharmacokinetic model of infection.
    MacGowan AP; Noel A; Tomaselli S; Elliott H; Bowker K
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1436-42. PubMed ID: 21263054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: Pharmacokinetic/Pharmacodynamic Targets for Vancomycin Exposure.
    Lenhard JR; Brown T; Rybak MJ; Meaney CJ; Norgard NB; Bulman ZP; Brazeau DA; Gill SR; Tsuji BT
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1584-91. PubMed ID: 26711763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged bacterial exposure to minocycline/rifampicin-impregnated vascular catheters does not affect antimicrobial activity of catheters.
    Aslam S; Darouiche RO
    J Antimicrob Chemother; 2007 Jul; 60(1):148-51. PubMed ID: 17525051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics of inhaled amikacin (BAY 41-6551) studied in an in vitro pharmacokinetic model of infection.
    Bowker KE; Noel AR; Tomaselli S; Attwood M; MacGowan AP
    J Antimicrob Chemother; 2018 May; 73(5):1305-1313. PubMed ID: 29562340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics of minocycline against Acinetobacter baumannii studied in a pharmacokinetic model of infection.
    Alfouzan WA; Noel AR; Bowker KE; Attwood MLG; Tomaselli SG; MacGowan AP
    Int J Antimicrob Agents; 2017 Dec; 50(6):715-717. PubMed ID: 28705678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased activity of linezolid in combination with rifampicin in a murine pneumonia model due to MRSA.
    Zhou YF; Xiong YQ; Tao MT; Li L; Bu MX; Sun J; Liao XP; Liu YH
    J Antimicrob Chemother; 2018 Jul; 73(7):1899-1907. PubMed ID: 29897466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of the antibacterial effect and emergence of resistance to tomopenem, formerly RO4908463/CS-023, in an in vitro pharmacokinetic model of Staphylococcus aureus infection.
    MacGowan AP; Bowker KE; Noel AR
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1401-6. PubMed ID: 18227179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of minocycline and rifampicin against methicillin- and gentamicin-resistant Staphylococcus aureus.
    Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F
    J Clin Pathol; 1981 May; 34(5):559-63. PubMed ID: 6910479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection.
    Bowker KE; Noel AR; MacGowan AP
    J Antimicrob Chemother; 2009 Nov; 64(5):1044-51. PubMed ID: 19759041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.
    Sambatakou H; Giamarellos-Bourboulis EJ; Grecka P; Chryssouli Z; Giamarellou H
    J Antimicrob Chemother; 1998 Mar; 41(3):349-55. PubMed ID: 9578161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of tigecycline alone and with rifampin in foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Garrigós C; Murillo O; Euba G; Verdaguer R; Tubau F; Cabellos C; Cabo J; Ariza J
    J Infect; 2011 Sep; 63(3):229-35. PubMed ID: 21763722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of AFN-1252, a novel FabI inhibitor, against Staphylococcus aureus in an in vitro pharmacodynamic model simulating human pharmacokinetics.
    Tsuji BT; Harigaya Y; Lesse AJ; Forrest A; Ngo D
    J Chemother; 2013 Feb; 25(1):32-5. PubMed ID: 23433442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.